Eric Lefkofsky’s Recent Healthcare Developments

Eric Lefkofsky is a Chicago based entrepreneur who together with others co-founded Tempus Labs. This is an institution that applies data analytics to provide solutions for cancer patients that will enable them to lead normal lives. The institution was created in 2015, and it has rapidly developed into one of the most reputable tech health startup bodies in the country. This development has been to a great extent due to the influence of Eric Lefkofsky. Eric and his wife Liz are philanthropists who have in the past given to numerous charity bodies. They have a group called Lefkofsky Family Foundation that has been active since its inception.

Tempus Labs is highly committed towards developing cancer remedies to people. The institution has formed mergers with numerous National Cancer Institutes in the country to ensure that they reach out to many patients as possible.
They offer a wide range of services that include the following:

Conducting of tests to diagnose the presence of cancer Characterization of tumors in a bid to give specific treatment solutions to the patients

Machine learning and use of patient data to create an effective treatment program. The efforts of Tempus Labs towards bringing relief to cancer patients have not gone unnoticed. Recently, the research institution was featured in the yearly Eric Topol’s listing that rates companies that merges healthcare with technology. Tempus Labs have been recommended for its efforts towards bringing changes to the health industry that are projected to revolutionize the entire sector in the near future.

Tempus has been highly rated due to its application of gene therapy and gene editing in the treatment of ailments that had no cure in the past. Through gene therapy, it is now possible to treat inherited loss of sight that was impossible to curb in the past and eventually led to blindness. Tests are still ongoing on the application of gene editing to treat Hunter syndrome, and the progress is positive.

Tempus Labs in collaboration with Stanford University have also been working on a formula to simplify skin cancer diagnosis. They have numerous other FDA approved developments that include glucose sensors that are used for direct injection of insulin to patients. Also on the list of their numerous works is an algorithm that can detect heart attacks and gives a signal before the problem escalates to uncontrollable levels.

About Eric Lefkofsky: www.lightbank.com/team/eric-lefkofsky

New Immunotherapies Could Be Cost Effective Says Dr. David Samadi

Using micrograms of two medicines, injected into mice, scientists saw cancerous tumors disappear. Lenox Hill Hospital head of Urology, Dr. David Samadi has written about this technique in a previous article, “Re-programming Your Body To Fight Cancer.” 90 mice were tested, and Standford University researchers say human clinical trials should begin by end of year.

This could be a quick and relatively inexpensive strategy, less expensive and with fewer side effects than other immunotherapies available today. The strategy developed aims to reactivate the ability of the immune system to recognize and destroy cancer cells. Dr. Samadi says this will be a pioneer in the field of immunotherapy.

The two medicines have two different functions: one is an amplifier of a particular receptor (OX40), which is present on the T cells of the immune system, while the second one binds to this receptor and guides against cancer.The mix worked well in laboratory mice with lymphoma that had the tumor transplanted into two distinct parts of the body. 87 out of 90 mice were healed from cancer. The researchers observed similar results in mice with breast, colon and cutaneous melanoma tumors.

According to Dr. David Samadi, these new immunotherapies are encouraging. This particular approach ignores the need to identify the tumor’s specific immune targets and does not require the general activation of the whole immune system. Hopefully, in the future, there won’t be a limit on the types of cancers that are treatable using this approach, added Dr. Samadi.

What Is Immunotherapy?

It’s a relatively new effective weapon to fight cancer and lengthen the long-term survival of patients. This technique aims at restoring the immune system using antibodies that “reactivate traffic lights” blocked by the tumor, so that the body can again attack the diseased cells. Continuation of clinical trials may result in a relatively inexpensive strategy at beating cancer says Dr. Samadi.

Dr. David Samadi specializes in urologic diseases, and is internationally known for his Samadi Modified Advanced Robotic Technique (SMART surgery). Dr. Samadii customized a prostate surgery procedure, resulting in a less invasive technique that cut down the surgery time, as well as the patient’s recovery time. This particular surgery protects the surrounding nerve bundles and Dr. Samadi has performed over 7,000 surgeries, domestically and internationally.

Dr. Samadi holds multiple “America’s Top Doctor” and “America’s Top Doctor for Cancer” awards, and was named “Best Doctor” for five consecutive years, and “Most Compassionate Doctor” from 2010 to 2013. In addition to his work at Lenox Hill Hospital, he is a medical correspondent for Fox News, and has his own show, Sunday Housecall, that airs on Sundays at 12:30pm.

For details: prostatecancer911.com/david-samadi/